Histone deacetylase inhibitors

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/19 (2006.01) C07C 259/04 (2006.01)

Patent

CA 2574035

This invention relates to iminodiacetic acid and diamine hydroxamic acid derivatives, that are inhibitors of histone deacetylase (HDAC), and are useful in the prevention and/or treatment of cellular proliferative diseases, for example cancer, autoimmune, allergic and inflammatory diseases, diseases of the central nervous system (CNS) such as neurodegenerative diseases, and in the prevention and/or treatment of restenosis.

L'invention porte sur des dérivés de l'acide iminodiacétique et de l'acide diamine hydroxamique, inhibiteurs de l'histone déacétylase (HDAC), et utilisables pour la prévention et/ou le traitement de maladies à prolifération cellulaire dont le cancer, et les maladies auto-immunes, allergiques ou inflammatoires, les troubles du SNC dont les maladies neurodégénératives, et pour la prévention et/ou le traitement des resténoses.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Histone deacetylase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Histone deacetylase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Histone deacetylase inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1413471

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.